Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2018 Filed Nov 17, 2018 00:44 UTC |
Gorsky AlexDirector · Chairman, CEO
|
Exercise / conversionCommon Stock | 144,695 | $62.20 | $9,000,029.00 |
DisclosureSEC source: 0001225208-18-015639 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 22:22 UTC |
Kapusta Ronald AController, CAO
|
SaleCommon Stock | 8,441 | $145.15 | $1,225,200.18 |
DisclosureSEC source: 0001225208-18-015373 · doc4.xml · nonDerivative · entry 1 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,284 F1 · price: This transaction was executed in multiple trades at prices ranging from $145.13 to $145.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 5,130 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,130 shares Expires 2019-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 15,577 | $0.00 Strike: $65.37 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,423 Underlying: Common Stock · 15,577 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 19,293 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,293 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
SaleCommon Stock | 40,000 | $144.36 | $5,774,480.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 4 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,555 F1 · price: This transaction was executed in multiple trades at prices ranging from $144.31 to $144.484. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 5,130 | $58.33 | $299,232.90 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 15,577 | $65.37 | $1,018,268.49 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC |
Duato JoaquinVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 19,293 | $62.20 | $1,200,024.60 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:43 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 319.566 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-013376 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,293.5443 Underlying: Common Stock · 319.566 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 20:43 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 364.156 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-013377 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,608.393 Underlying: Common Stock · 364.156 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 19:53 UTC |
Kapusta Ronald AController, CAO
|
SaleCommon Stock | 7,899 | $137.18 | $1,083,606.94 |
DisclosureSEC source: 0001225208-18-013320 · doc4.xml · nonDerivative · entry 1 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,725 F1 · price: This transaction was executed in multiple trades at prices ranging from $137.17 to $137.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 29,000 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001225208-18-012945 · doc4.xml · derivative · entry 5 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,943 Underlying: Common Stock · 29,000 shares Expires 2019-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
SaleCommon Stock | 29,000 | $134.80 | $3,909,084.00 |
DisclosureSEC source: 0001225208-18-012945 · doc4.xml · nonDerivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,124 F1 · price: This transaction was executed in multiple trades at prices ranging from $134.781 to $134.860. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 20:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 29,000 | $58.33 | $1,691,570.00 |
DisclosureSEC source: 0001225208-18-012945 · doc4.xml · nonDerivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2018 Filed Sep 17, 2018 21:51 UTC |
McEvoy AshleyEVP, WW Chair, Medical Devices
|
OtherCommon Stock | 142 | $134.92 | $19,158.64 |
DisclosureSEC source: 0001225208-18-013499 · doc4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices 10b5-1 filing: Not disclosed Ownership: Indirect · By 401k Disclosed balance after: 2,215 F1 · balance_after: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 22:59 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 354.168 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010699 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,973.9783 Underlying: Common Stock · 354.168 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 22:59 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 403.586 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010700 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,244.237 Underlying: Common Stock · 403.586 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| April 05, 2018 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,984.882 F1 · price: Gift Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 18:00 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 318.475 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006205 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,619.8103 Underlying: Common Stock · 318.475 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 18:00 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 363.404 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006206 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,840.651 Underlying: Common Stock · 363.404 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| March 09, 2018 Filed Feb 13, 2019 02:15 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 380 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002354 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,369.882 F1 · price: Gift Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 155,342 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 155,342 shares Expires 2024-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
SaleCommon Stock | 155,342 | $129.86 | $20,172,401.44 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,564.3468 F1 · price: This transaction was executed in multiple trades at prices ranging from $129.435 to $130.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionCommon Stock | 155,342 | $90.44 | $14,049,130.48 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,906.3468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:11 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003067 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,695.382 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:11 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003068 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,350.743 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:11 UTC |
Davis IanDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003069 · doc4.xml · derivative · entry 1 Davis Ian · CIK 0001494009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,304.116 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:11 UTC |
McClellan Mark B.Director
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003070 · doc4.xml · derivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,262.236 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:11 UTC |
MULCAHY ANNE MDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003071 · doc4.xml · derivative · entry 1 MULCAHY ANNE M · CIK 0001201725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,304.116 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:12 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003072 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,259.559 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:13 UTC |
PRINCE CHARLESDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003073 · doc4.xml · derivative · entry 1 PRINCE CHARLES · CIK 0001225179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,703.387 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:16 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003074 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,301.3353 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 23:17 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-003075 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,477.247 Underlying: Common Stock · 1,428 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
GrantRestricted Share Units · Derivative | 4,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · derivative · entry 8 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,312 Underlying: Common Stock · 4,312 shares Expires not disclosed F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionPerformance Share Units · Derivative | 26,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · derivative · entry 7 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 85,948 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · derivative · entry 6 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,948 Underlying: Common Stock · 85,948 shares Expires 2028-02-12 F6 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Tax withholdingCommon Stock | 15,652 | $129.51 | $2,027,090.52 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · nonDerivative · entry 3 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,659 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
GrantCommon Stock | 9,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · nonDerivative · entry 2 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,311 F2 · shares: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionCommon Stock | 26,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002945 · doc4.xml · nonDerivative · entry 1 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · derivative · entry 6 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 Underlying: Common Stock · 2,060 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionPerformance Share Units · Derivative | 14,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · derivative · entry 5 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 41,055 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · derivative · entry 4 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,055 Underlying: Common Stock · 41,055 shares Expires 2028-02-12 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 9,471 | $129.51 | $1,226,589.21 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · nonDerivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,327.0055 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantCommon Stock | 5,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,798.0055 F2 · shares: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 14,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002946 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,551.0055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantRestricted Share Units · Derivative | 5,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,283 Underlying: Common Stock · 5,283 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionPerformance Share Units · Derivative | 24,530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 105,307 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,307 Underlying: Common Stock · 105,307 shares Expires 2028-02-12 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Tax withholdingCommon Stock | 14,486 | $129.51 | $1,876,081.86 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,555 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.